Social media

ICON is pleased to participate in #CPHIFrankfurt, taking place from 28 to 30 October at Messe Frankfurt. Visit us at booth 6.1F95 to learn how ICON’s Accelerated Pharmaceutical Solutions are helping partners bring therap...

ICON is pleased to participate in #CPHIFrankfurt, taking place from 28 to 30 October at Messe Frankfurt. Visit us at booth 6.1F95 to learn how ICON’s Accelerated Pharmaceutical Solutions are helping partners bring therap...

Approximately 11% of sites failing to recruit a single patient. Visit us at #ESMO25, booth \#3034 to learn about One Search, ICON’s award winning, AI-driven site selection tool to help identify the right sites the first ...

Approximately 11% of sites failing to recruit a single patient. Visit us at #ESMO25, booth #3034 to learn about One Search, ICON’s award winning, AI-driven site selection tool to help identify the right sites the first t...

The oncology biologics with patents expiring over the next several years are increasingly complex, each modality presenting its own unique hurdles for biosimilar development. Read ICON’s article in Drug Discovery & Devel...

The oncology biologics with patents expiring over the next several years are increasingly complex, each modality presenting its own unique hurdles for biosimilar development. Read ICON’s article in Drug Discovery & Devel...

From early planning to execution, ICON supports your obesity trials with strategic insight, operational excellence, and proven infrastructure. See how in our case studies. https://ow.ly/kStl50WY1c1

From early planning to execution, ICON supports your obesity trials with strategic insight, operational excellence, and proven infrastructure. See how in our case studies. https://ow.ly/cC6Q50WY1bY

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...

In honour of World Heart Day, ICON is spotlighting the importance of cardiovascular studies, which are critical to protecting and advancing heart health. In our blog, learn how CV studies can use digital health technolog...

In just two days Andrew Roche, Senior Director of Scientific Affairs, will present at the Biomarkers & Precision Medicine conference. His session, “Key considerations for high-quality data generation in global clinical ...